Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile
Onyema Ogbuagu

@dronyemaogbuagu

Inf diseases MD, FACP, FIDSA,
Assoc Prof Medicine & Pharmacology @ Yale. HHS ARV panel.

I love conducting trials for treatment/prevention of stubborn viruses!

ID: 1271098579260715014

calendar_today11-06-2020 15:14:59

922 Tweet

13,13K Followers

68 Following

Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

Watch this space...if this continues, we will see resurgence of vaccine preventable illness (kinda happening already) Good thing is vaccinated people will be relatively spared... nbcnews.com/health/health-…

Contagion (@contagion_live) 's Twitter Profile Photo

Dr. Onyema Ogbuagu from Yale School of Medicine discussed results from Phase 2 study evaluating LEN, TAB, and ZAB, every 6 months for HIV-1 treatment. The study found 96% virologic suppression at Week 26, similar to daily oral ART. #CROI2025 Gilead Sciences contagionlive.com/view/phase-2-s…

Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

Another death of a child from measles in the US! Breaks my heart because these deaths are preventable! Some people who argue about protecting the unborn, seem to think diffetently about protecting children I dont understand it!

Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

Wonderful to have spent last week in Dubai at the 9th Middle East HIV summit Proud of the work being done to combat HIV by amazing, resilient and visionary clinicians, researchers, policymakers in the region. Clear roadmap as to what needs to be done to acheieve epidemic control!

Wonderful to have spent last week in Dubai at the 9th Middle East HIV summit
Proud of the work being done to combat HIV by amazing, resilient and visionary clinicians, researchers, policymakers in the region. Clear roadmap as to what needs to be done to acheieve epidemic control!
Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

Clear example of when broad ranging recomme dations are made to address rare events...in this case delayed or atypical HIV seroconversions for those using oral or injectable PrEP Study shows time to stop doing viral load tests on everyone using oral PrEP academic.oup.com/cid/advance-ar…

Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

Yeztugo, a.k.a "yes to go" is new trade name for lenacapavir for HIV PrEP approved today by FDA! Price point $14k per dose, given twice yearly, seems priced to be at par with IM CAB and oral TAF/FTC for PrEP. Generic licences for LMIC access / lower cost. npr.org/sections/goats…

Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

IAS 2025 opening ceremony Its president Bridget Grinsztejn said "science is backbone of HIV response yielding HAART, PrEP, PEP, U=U". Hoping for more breakthorughs in vaccines, long acting injections, cure. Called out concerns on access to lenacapavir for midlde income countries.

IAS 2025 opening ceremony
Its president Bridget Grinsztejn said "science is backbone of HIV response yielding HAART, PrEP, PEP, U=U". Hoping for more breakthorughs in vaccines, long acting injections, cure. Called out concerns on access to lenacapavir for midlde income countries.
Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

IAS 2025 comments by conference co-chair- Jeanine Condo- dressed in Rwandan traditional attire "imishanana", emphasizes (and I AGREE) that African countries, disproportionately impacted by HIV, should decrease donor dependency, increase financing and strengthen health systems.

Onyema Ogbuagu (@dronyemaogbuagu) 's Twitter Profile Photo

IAS 2025 opening ceremony Loving powerful quotes by Rosemary Mburu (Kenya)- "Community action is what gives science its soul" "Communities remain strategic brain of "HIV" response" "...for what could be last chapter of HIV response, ...follow the lead of communities..."